Revenue (Tables)

6 Months Ended

Jun. 30, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	Three Months Ended June 30,		Six Months Ended June 30,
	2022	2021	2022	2021
Biologics	43 %	41 %	43 %	40 %
Generics	18 %	16 %	17 %	17 %
Pharma	24 %	24 %	24 %	24 %
Contract-Manufactured Products	15 %	19 %	16 %	19 %
	100 %	100 %	100 %	100 %

The following table presents the approximate percentage of our net sales by product category:

	Three Months Ended June 30,		Six Months Ended June 30,
	2022	2021	2022	2021
High-Value Product Components	57 %	55 %	56 %	54 %
High-Value Product Delivery Devices	5 %	4 %	5 %	4 %
Standard Packaging	23 %	22 %	23 %	23 %
Contract-Manufactured Products	15 %	19 %	16 %	19 %
	100 %	100 %	100 %	100 %

The following table presents the approximate percentage of our net sales by geographic location:

	Three Months Ended June 30,		Six Months Ended June 30,
	2022	2021	2022	2021
Americas	47 %	43 %	46 %	45 %
Europe, Middle East, Africa	45 %	47 %	45 %	45 %
Asia Pacific	8 %	10 %	9 %	10 %
	100 %	100 %	100 %	100 %

Schedule of Change in Contract with Customer, Asset and Liability

The following table summarizes our contract assets and liabilities:

	($ in millions)
Contract assets, December 31, 2021	$	14.6
Contract assets, June 30, 2022	14.8
Change in contract assets - increase (decrease)	$	0.2
Deferred income, December 31, 2021	$	(61.3)
Deferred income, June 30, 2022	(65.9)
Change in deferred income - (increase) decrease	$	(4.6)